In Rossille's study,[21] elevated sPD-L1 was correlated with a poorer prognosis for patients with B-cell lymphoma treated with R-CHOP chemotherapy (P < 0.001), using a cutoff of 1.52 ng/mL for PD-L1 level. Here, SPDL1 is linked to B-cell non-Hodgkin lymphoma.